MORRISVILLE, N.C., July 19, 2022 – Dr. Melgar presented five cases where she demonstrated the clinical value of MyoStrain® over traditional metrics and current standard of care protocols. She evaluated and explained how MyoStrain provides additional information when making treatment decisions.
In all five cases, the information from MyoStrain either helped confirm her suspicions, validated existing treatment results, or helped determine a proper course of treatment.
Dr. Melgar is an advocate of MyoStrain and, from her experience, believes that MyoStrain should be a first-line test for its reproducibility, accuracy, and sensitivity to detect early dysfunction over current imaging and testing modalities to obtain a general assessment of a patient’s heart. She confirmed that the MyoStrain report provides a wealth of new data and understanding that is not available through traditional testing.
Dr. Melgar stated, “MyoStrain could improve early decision-making efficiency by replacing current traditional metrics and other testing modalities and improving the lead times to schedule unwarranted testing.”
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.